These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26925801)

  • 1. Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity.
    Malaspina D; Kranz TM; Heguy A; Harroch S; Mazgaj R; Rothman K; Berns A; Hasan S; Antonius D; Goetz R; Lazar M; Chao MV; Gonen O
    Schizophr Res; 2016 Apr; 172(1-3):94-100. PubMed ID: 26925801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes.
    Kranz TM; Berns A; Shields J; Rothman K; Walsh-Messinger J; Goetz RR; Chao MV; Malaspina D
    EBioMedicine; 2016 Apr; 6():206-214. PubMed ID: 27211562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypo-metabolism of the rostral anterior cingulate cortex associated with working memory impairment in 18 cases of schizophrenia.
    Mazgaj R; Tal A; Goetz R; Lazar M; Rothman K; Messinger JW; Malaspina D; Gonen O
    Brain Imaging Behav; 2016 Mar; 10(1):115-23. PubMed ID: 25804309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia.
    Callicott JH; Bertolino A; Egan MF; Mattay VS; Langheim FJ; Weinberger DR
    Am J Psychiatry; 2000 Oct; 157(10):1646-51. PubMed ID: 11007719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia.
    Jessen F; Fingerhut N; Sprinkart AM; Kühn KU; Petrovsky N; Maier W; Schild HH; Block W; Wagner M; Träber F
    Schizophr Bull; 2013 Jan; 39(1):197-205. PubMed ID: 21914645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.
    Ohrmann P; Kugel H; Bauer J; Siegmund A; Kölkebeck K; Suslow T; Wiedl KH; Rothermundt M; Arolt V; Pedersen A
    Schizophr Res; 2008 Dec; 106(2-3):156-63. PubMed ID: 18799290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample.
    Kranz TM; Harroch S; Manor O; Lichtenberg P; Friedlander Y; Seandel M; Harkavy-Friedman J; Walsh-Messinger J; Dolgalev I; Heguy A; Chao MV; Malaspina D
    Schizophr Res; 2015 Aug; 166(1-3):119-24. PubMed ID: 26091878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: a (1)H MRS study at 3Tesla.
    Crocker CE; Bernier DC; Hanstock CC; Lakusta B; Purdon SE; Seres P; Tibbo PG
    Schizophr Res; 2014 Aug; 157(1-3):231-7. PubMed ID: 24906219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between prefrontal N-acetylaspartate and insight in psychotic disorders.
    Larabi DI; Liemburg EJ; Pijnenborg GH; Sibeijn-Kuiper A; de Vos AE; Bais L; Knegtering H; Ćurčić-Blake B; Aleman A
    Schizophr Res; 2017 Jan; 179():112-118. PubMed ID: 27658999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Bilateral Prefrontal rTMS on Left Prefrontal NAA and Glx Levels in Schizophrenia Patients with Predominant Negative Symptoms: An Exploratory Study.
    Dlabac-de Lange JJ; Liemburg EJ; Bais L; van de Poel-Mustafayeva AT; de Lange-de Klerk ESM; Knegtering H; Aleman A
    Brain Stimul; 2017; 10(1):59-64. PubMed ID: 27615793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
    Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
    Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
    Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.
    Zong X; Hu M; Li Z; Cao H; He Y; Liao Y; Zhou J; Sang D; Zhao H; Tang J; Lv L; Chen X
    Sci Rep; 2015 Mar; 5():9109. PubMed ID: 25778460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia.
    Bertolino A; Knable MB; Saunders RC; Callicott JH; Kolachana B; Mattay VS; Bachevalier J; Frank JA; Egan M; Weinberger DR
    Biol Psychiatry; 1999 Mar; 45(6):660-7. PubMed ID: 10187995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Reid MA; White DM; Kraguljac NV; Lahti AC
    Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
    Deicken RF; Zhou L; Schuff N; Weiner MW
    Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
    Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.